544529

Aptus Pharma Limited has undertaken a strategic brand-building initiative by taking over the Baby Care Room at Rajkot Hirasar Airport. This is to promote its upcoming baby care and OTC product portfolio, enhance brand visibility among travellers and families, and strengthen awareness of its expanding healthcare range. The initiative aims to strengthen customer trust, improve market reach, and establish a stronger presence in the OTC and baby care segment.

Kripaliben Mayank Thakker, identified as part of the Promoter Group of Aptus Pharma Limited, disclosed the acquisition of 18,000 equity shares (0.26%) of the company on May 11, 2026. This transaction was an off-market inter-se transfer among the Promoter Group. Her shareholding increased from 5,75,000 shares (8.38%) before the acquisition to 5,93,000 shares (8.64%) after the acquisition.

Kunjal Piyushbhai Unadkat, a promoter of Aptus Pharma Limited, acquired 18,000 equity shares (0.26%) of the company on May 11, 2026. This off-market inter-se transfer within the promoter group increased his total holding from 8.38% to 8.64% of the total share capital.

Riddhish Natwarlal Tanna, part of the promoter group of Aptus Pharma Limited, disclosed an acquisition of 18,000 equity shares (0.26%) of the company on May 11, 2026. This was an off-market inter-se transfer within the promoter group, increasing the total promoter group holding from 8.38% (5,75,000 shares) to 8.64% (5,93,000 shares).

Milly Chetan Lalseta, part of the Promoter/Promoter Group, acquired 18,000 equity shares of Aptus Pharma Limited via an off-market inter-se transfer on May 11, 2026. This acquisition increased the promoter group's total shareholding from 5,75,000 shares (8.38%) to 5,93,000 shares (8.64%). The disclosure was made under Regulation 29(1)/29(2) of SEBI (SAST) Regulations, 2011.

Gaurang Rameshchandra Thakker, a promoter of Aptus Pharma Limited, acquired 18,000 equity shares of the company on May 11, 2026. This off-market inter-se transfer increased his holding from 5,75,000 shares (8.38%) to 5,93,000 shares (8.64%) of the total voting capital. The acquisition represents a 0.26% increase in his stake.

Mr. Chatrabhuj Vallabhbhai Butani, a promoter of Aptus Pharma Limited, disclosed an off-market inter-se transfer/sale of 1,24,000 equity shares (1.81%) on May 11, 2026. His holding reduced from 2,25,000 shares (3.28%) to 1,01,000 shares (1.47%) as a result of this transaction within the promoter group.

Ghanshyam Vinubhai Pansuriya, part of the Promoter Group of Aptus Pharma Limited, disclosed the acquisition of 14,000 equity shares through an off-market inter-se transfer on May 11, 2026. This increased the promoter's holding from 3,50,000 shares (5.10%) to 3,64,000 shares (5.31%) in the company.

Tejash Maheshchandra Hathi, a promoter of Aptus Pharma Limited, acquired 10,000 equity shares off-market on May 11, 2026. This acquisition increased the promoter's holding from 7,75,000 shares (11.30% of total voting capital) to 7,85,000 shares (11.44% of total voting capital). The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

Kapilbhai Hasmukhbhai Chandarana, belonging to the Promoter Group of Aptus Pharma Limited, acquired 10,000 equity shares off-market on May 11, 2026. This acquisition increased the promoter group's holding from 7,75,000 shares (11.30%) to 7,85,000 shares (11.44%) of the company's total share capital.